BATS BZX Real-Time Price
As of 1:18pm ET
| +0.01 / +0.02%|
The 32 analysts offering 12-month price forecasts for Novo Nordisk have a median target of 41.11, with a high estimate of 51.34 and a low estimate of 28.90. The median estimate represents a -0.96% decrease from the last price of 41.51.
The current consensus among 34 polled investment analysts is to Hold stock in Novo Nordisk. This rating has held steady since May, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.